The human heart beats over two billion times in the average lifetime, and pumps nearly 100 million barrels of blood. If you were to take the vessels through which your blood flows, and lay them out end to end, they would circle the globe four times. Your cardiovascular symptom includes your heart, blood and blood vessels. Mechanically speaking, it transports not just blood, but also hormones, enzymes, nutrients and other chemicals your body needs. And as science is just beginning to understand, it communicates with your brain.
Because this system is one of the dozen or so that are absolutely critical to your survival, protecting your heart is a prime consideration. Now, scientists are recommending a natural way to do that, by supplementing with Coenzyme Q10. CoQ10 is a vitamin-like substance which many health experts believe is more effective at treating high cholesterol and coronary artery disease than the widely-prescribed statin drugs.
CoQ10 occurs naturally in every cell in your body. The body manufactures it for energy, cell growth and health. It is considered a “super” antioxidant, because it minimizes free radical damage and retards aging. It also helps in food digestion, muscle strength and recovery from activity, and reducing inflammation.
Statin drugs have been used to treat dyslipidemia, or high cholesterol, for almost three decades. Although they are effective in lowering cholesterol, they have a number of reported side effects. These include liver problems, diabetes and cognitive impairment. Also, many health experts doubt that simply lowering cholesterol is the answer to cardiovascular problems.
A recent study published in The American Journal of Cardiology proved the usefulness of coenzyme Q10 in treating patients with elevated cholesterol and heart disease. Participants were divided into subgroups. One took Ezetimibe, a drug designed to lower plasma cholesterol levels. The second took CoQ10 in a nutraceutical combination. After 3 months, the levels in the Ezetimibe subgroup were unchanged, but patients in the CoQ10 group experienced positive changes. At that point, Coenzyme Q10 was added to the Ezetimibe used by the first group, and when the treatment was completed, the group had achieved 72.5 percent of their therapeutic target. The subgroup that took only CoQ10 had 100 percent success.
Other research has shown CoQ10 to be effective in treating chronic heart failure, hypertension, and endothelial dysfunction. It has proved to be safe and well tolerated by patients. Very recent research, published in PLoS One, shows CoQ10 significantly reduces cardiovascular mortality unto 10 years after intervention. The study included 443 healthy elderly participants. During 4 years of the study, the participants took CoQ10 along with selenium, another antioxidant the level of which declines with age. The followup study demonstrated that the protection action of CoQ10 continued during the 10 years beyond the original 4-year study. Both men and women were part of this study.
CoQ10 is also beneficial in treating cancer, muscular dystrophy, periodontal disease, mitrochrondial myopathies and neurodegenerative diseases.